New Product
Commercialization
Focus commercialization pathways on your perfect product-market fit and pinpoint market opportunities with precision.
MORE
Growth
Acceleration
Supercharge your commercial teams with comprehensive, up-to-date market and customer intelligence to rapidly scale market impact.
MORE
Market Segments
Medtech Diagnostics Digital Health Drug Delivery BioPharma
Article

S2N Health Welcomes
Amy Brouhle as VP of Strategic Business Development

Amy Brouhle as VP of Strategic Business Development

S2N Health, a leader in AI-powered commercial intelligence solutions for MedTech companies, is proud to announce the appointment of Amy Brouhle, RN, BSN, MBA, MHA as Vice President of Strategic Business Development. This expansion of the senior leadership team will empower S2N to focus on new growth initiatives, forge key industry partnerships, and drive the adoption of RepSignal®, S2N’s commercial intelligence platform.    

“S2N Health is at the forefront of revolutionizing MedTech commercialization with AI-driven insights,” said Brouhle. “I’m excited to join the team and contribute to expanding our impact across the industry.” 

Amy brings over 25 years of experience in MedTech commercialization, having previously held multiple leadership positions across the healthcare vertical including medtech, pharma, and provider segments. Her expertise in leading at the intersection of commercial growth and strategy—combined with her unique clinical perspective as a registered nurse—will be instrumental in accelerating S2N Health’s mission to harness the power of data, analytics, and AI to catalyze growth while maximizing commercial efficiencies. 

“The addition of Amy Brouhle to our leadership team enhances our ability to be a transformative business partner to our MedTech customers,” said S2N Health CEO Amy Siegel. “Amy brings a wealth of experience in engaging MedTech leadership to solve big commercial challenges with actionable intelligence.”  

As MedTech companies face increasing pressures to maximize sales efficiency, S2N Health will continue to expand our impact on the future of commercialization with additions to our team, product, and data assets. To stay current with S2N’s continuing evolution, click the link at the bottom of the page to subscribe to updates & news.